Preferred Label : Anti-spike Protein SARS-CoV-2 Monoclonal Antibody;
NCIt synonyms : Anti-SARS-CoV-2 S Protein Monoclonal Antibody; Anti-SARS-CoV-2 Spike Protein Monoclonal Antibody; Anti-SARS-CoV-2 Coronavirus Spike Protein Monoclonal Antibody;
NCIt related terms : Monoclonal antibodies against SARS-CoV-2;
NCIt definition : Any monoclonal antibody that is directed against the spike (S) protein of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2).;
Alternative definition : ACC/AHA: Any monoclonal antibody that is directed against the spike (S) protein of
SARS-CoV-2;
NCI Metathesaurus CUI : CL1407554;
Origin ID : C173741;
UMLS CUI : C5420363;
Semantic type(s)
chemical_or_drug_has_mechanism_of_action
concept_is_in_subset
https://www.ema.europa.eu/en/medicines/human/EPAR/kavigale
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
Sipavibart
drug approval
europe
Sipavibart
sipavibart
adolescent
adult
immunocompromised host
COVID-19
infusions, intravenous
injections, intramuscular
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
antibodies, monoclonal
antibodies, monoclonal
product surveillance, postmarketing
Pre-Exposure Prophylaxis
---
https://www.cochrane.org/fr/CD014945/HAEMATOL_les-anticorps-monoclonaux-specifiques-de-la-covid-19-fabriques-en-laboratoire-sont-ils-efficaces
2022
false
false
false
United Kingdom
COVID-19
cilgavimab and tixagevimab drug combination
casirivimab and imdevimab drug combination
bamlanivimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
review of literature
french abstract
antibodies, monoclonal
---
https://www.ansm.sante.fr/actualites/anticorps-monoclonaux-lansm-permet-lutilisation-en-acces-precoce-de-deux-bitherapies-contre-la-covid-19
2021
false
false
false
France
French
scientific and technical information
drug information
antibodies, monoclonal
adult
Casirivimab/Imdevimab
Casirivimab
Imdevimab
Anti-spike Protein SARS-CoV-2 Monoclonal Antibody
Bamlanivimab
Etesevimab
aged
spike glycoprotein, coronavirus
france
drug monitoring
risk
drug combinations
casirivimab and imdevimab drug combination
COVID-19
COVID-19
casirivimab
imdevimab
casirivimab and imdevimab
drug combinations
antibodies, monoclonal, humanized
Product containing only casirivimab and imdevimab in parenteral dose form (medicinal
product form)
casirivimab and imdevimab drug combination
---